PKCι and YAP1 are crucial in promoting pancreatic tumorigenesis

Pancreatic ductal adenocarcinoma (PDAC) is a fatal malignant disease with 5-year survival rate of less than 6%. Activating mutations of Kras (mu-Kras) are often detected in most of PDAC patients. Although it has been known that oncogenic Kras is the driver of pancreatic cancer initiation and develop...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Peipei, Wei, Dapeng, Zhang, Hongmei, Chen, Jiao, Zhang, Dingding, Ganapathy, Suthakar, Isakson, Pauline, Chen, Changyan, Zhu, Tongbo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132349/
https://www.ncbi.nlm.nih.gov/pubmed/30214681
http://dx.doi.org/10.18632/oncotarget.25127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6132349/
https://www.ncbi.nlm.nih.gov/pubmed/30214681
http://dx.doi.org/10.18632/oncotarget.25127

Ejemplares similares